Speakers

Rafiq Hasan

Chief Executive Officer • Complement Therapeutics

Rafiq has pursued a highly successful career in the pharma industry globally, including senior positions in ophthalmology with Bayer and Novartis. Most recently as SVP and Global Head of Ophthalmology at Bayer, Rafiq grew the business of Eylea® from launch to over USD 2.5bn in 5 years, including its launch in 5 indications in 3 years.

Also speaking

Raja Sharif

Founder & Chief Executive Officer • Hataali

Takis Athanasopoulos

Chief Executive Officer, Gene & Cell Ltd., Vice President, Gene Therapy Research & Vector Technology • ViGeneron

Lynn Fischer

Chief Executive Officer • TITLE21 Health Solutions

Event Info

Image

Sponsorship Opportunities Waiting List

Take a look at the sample attendee list for Advanced Therapies Europe 2023 here.
Image

Partnering

Find out more about partnering at Advanced Therapies Europe.